1. WHO. Global action plan on HIV drug resistance 2017–2021. Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.
2. Zuo L, Liu K, Liu H, et al. Trend of HIV-1 drug resistance in China: a systematic review and meta-analysis of data accumulated over 17 years (2001–2017). EClin Med. 2020;18: 100238.
3. HIVDB Genotypic Resistance Test (GRT) Interpretation System. Updated October 2019. https://cms.hivdb.org/prod/downloads/release-notes/genotypic-resistance-test-interpretation-system-oct2019.pdf. Accessed 19 Aug 2022.
4. Liu Y, Zhang Y, Li H, et al. Natural presence of the V179D and K103R/V179D mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors in HIV-1 CRF65_cpx strains. BMC Infect Dis. 2020;20(1):313.
5. Liu Y, Li H, Wang X, et al. Natural presence of V179E and rising prevalence of E138G in HIV-1 reverse transcriptase in CRF55_01B viruses. Infect Genet Evol. 2020;77: 104098.